Skip to main content

Written question asked by Andy MacNae (Labour) on Monday, 17 November 2025, in the House of Commons. It was due for an answer on Wednesday, 19 November 2025. It was answered by Ashley Dalton (Labour) on Monday, 24 November 2025 on behalf of the Department of Health and Social Care.


Streptococcus: Notifiable Diseases

Question

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of designating group B Streptococcus as a notifiable disease.

Answer

The UK Health Security Agency (UKHSA) does not recommend adding Group B Streptococcus as a notifiable disease. Existing national surveillance effectively captures Group B Streptococcus infections, monitors trends, and informs antibiotic prescribing policy. The UKHSA has assessed that mandatory notification for Group B Streptococcus would provide no additional public health benefit beyond this.


Secondary information

Type
Written question
Reference
91494
Session
2024-26
Related items
Streptococcus: Notifiable Diseases
Wednesday, 14 January 2026
Written questions
House of Commons
Subjects
Notifiable diseases Streptococcus
Link
View this Written question on www.parliament.uk